These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22713155)

  • 21. Epidemiology and natural history of atherosclerotic renovascular disease.
    Chrysochou C; Kalra PA
    Prog Cardiovasc Dis; 2009; 52(3):184-95. PubMed ID: 19917329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease.
    Silva VS; Martin LC; Franco RJ; Carvalho FC; Bregagnollo EA; Castro JH; Gavras I; Gavras H
    Am J Hypertens; 2008 Oct; 21(10):1163-8. PubMed ID: 18670414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revascularization versus medical therapy for renal-artery stenosis.
    ; Wheatley K; Ives N; Gray R; Kalra PA; Moss JG; Baigent C; Carr S; Chalmers N; Eadington D; Hamilton G; Lipkin G; Nicholson A; Scoble J
    N Engl J Med; 2009 Nov; 361(20):1953-62. PubMed ID: 19907042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Predictors of successful renal artery revascularization in atherosclerotic renovascular disease].
    Flisiński M; Manitius J
    Pol Merkur Lekarski; 2005 Aug; 19(110):206-10. PubMed ID: 16245436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atherosclerotic nephropathy. Clinical manifestations of chronic arterial circulatory insufficiency of the kidneys].
    Krapf R
    Schweiz Med Wochenschr; 1990 Sep; 120(39):1415-20. PubMed ID: 2218463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy?
    Greco BA; Breyer JA
    Semin Nephrol; 1996 Jan; 16(1):2-11. PubMed ID: 8720081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?
    Karagiannis A; Tziomalos K; Anagnostis P; Gossios T; Athyros VG
    Angiology; 2009; 60(4):397-402. PubMed ID: 19505885
    [No Abstract]   [Full Text] [Related]  

  • 29. [Management of atherosclerotic renal-artery stenosis in 2016].
    Fournier T; Sens F; Rouvière O; Millon A; Juillard L
    Nephrol Ther; 2017 Feb; 13(1):1-8. PubMed ID: 27887845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current world literature.
    Curr Opin Cardiol; 2012 Jul; 27(4):441-54. PubMed ID: 22678411
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemiology and clinical presentation.
    Textor SC
    Semin Nephrol; 2000 Sep; 20(5):426-31. PubMed ID: 11022894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of atherosclerotic renal artery stenosis.
    Peixoto AJ; Ditchel LM; Santos SF
    Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1317-24. PubMed ID: 20828354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiometabolic risk-factor management.
    Ker J
    Cardiovasc J Afr; 2008; 19(4):222-4. PubMed ID: 18776972
    [No Abstract]   [Full Text] [Related]  

  • 35. Atherosclerotic renal artery stenosis and renal artery stenting: an evolving therapeutic option.
    Margey R; Hynes BG; Moran D; Kiernan TJ; Jaff MR
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1347-60. PubMed ID: 21985547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stenting atherosclerotic renal arteries: time to be less aggressive.
    Simon JF
    Cleve Clin J Med; 2010 Mar; 77(3):178-89. PubMed ID: 20200168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endovascular versus medical therapy for atherosclerotic renovascular disease.
    Yu MS; Folt DA; Drummond CA; Haller ST; Cooper EL; Brewster P; Evans KL; Cooper CJ
    Curr Atheroscler Rep; 2014 Dec; 16(12):459. PubMed ID: 25301353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of revascularization of atherosclerotic renal artery stenosis on coronary flow reserve and peripheral endothelial function.
    Koivuviita N; Tertti R; Luotolahti M; Raitakari O; Vahlberg T; Nuutila P; Knuuti J; Metsärinne K
    Nephron Clin Pract; 2011; 118(3):c241-8. PubMed ID: 21196769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current management of atherosclerotic renovascular disease--what have we learned from ASTRAL?
    Chrysochou C; Kalra PA
    Nephron Clin Pract; 2010; 115(1):c73-81. PubMed ID: 20185934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The CORAL study].
    Marchese A; Lonati LM
    G Ital Cardiol (Rome); 2014 Sep; 15(9):455-9. PubMed ID: 25298353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.